253 related articles for article (PubMed ID: 2501548)
1. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
[TBL] [Abstract][Full Text] [Related]
2. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
Langleben D; Reid LM
Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
[TBL] [Abstract][Full Text] [Related]
3. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
Mathew R; Altura BT; Altura BM
Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
6. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
[TBL] [Abstract][Full Text] [Related]
7. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
8. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
[TBL] [Abstract][Full Text] [Related]
9. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
[TBL] [Abstract][Full Text] [Related]
10. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
11. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
Correia-Pinto J; Henriques-Coelho T; Roncon-Albuquerque R; Lourenço AP; Melo-Rocha G; Vasques-Nóvoa F; Gillebert TC; Leite-Moreira AF
Basic Res Cardiol; 2009 Sep; 104(5):535-45. PubMed ID: 19288153
[TBL] [Abstract][Full Text] [Related]
12. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension.
Kato S; Sugimura H; Kishiro I; Machida M; Suzuki H; Kaneko N
Exp Lung Res; 2002 Jun; 28(4):265-73. PubMed ID: 12042029
[TBL] [Abstract][Full Text] [Related]
15. Single lung transplantation in rats with fatal pulmonary hypertension.
Kawaguchi AT; Kawashima Y; Mizuta T; Ishibashi-Ueda H; Kanosue K; Shirakura R; Matsuda H
J Thorac Cardiovasc Surg; 1992 Sep; 104(3):825-9. PubMed ID: 1387440
[TBL] [Abstract][Full Text] [Related]
16. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
17. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
[TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
19. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
Kodama K; Adachi H
J Pharmacol Exp Ther; 1999 Aug; 290(2):748-52. PubMed ID: 10411587
[TBL] [Abstract][Full Text] [Related]
20. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
